J M Cavaillon Selected Research

Cryptococcosis

1/2001	Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus.
6/2000	Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J M Cavaillon Research Topics

Disease

6	Sepsis (Septicemia) 08/2001 - 01/2000
5	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2001 - 01/2000
2	Wounds and Injuries (Trauma) 07/2001 - 11/2000
2	Inflammation (Inflammations) 06/2001 - 01/2000
2	Cryptococcosis 01/2001 - 06/2000
1	Necrosis 08/2001
1	Mycoses (Diseases, Fungus) 06/2000
1	Septic Shock (Toxic Shock Syndrome) 05/2000
1	Shock 05/2000
1	Body Weight (Weight, Body) 05/2000

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 07/2001 - 01/2000
5	LipopolysaccharidesIBA 01/2001 - 01/2000
4	Interleukin-10 (Interleukin 10)IBA 07/2001 - 01/2000
2	NF-kappa B (NF-kB)IBA 07/2001 - 11/2000
1	Fas Ligand Protein (Fas Ligand)IBA 08/2001
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 08/2001
1	Proteins (Proteins, Gene)FDA Link 08/2001
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2001
1	I-kappa B Proteins (I kappa B)IBA 07/2001
1	InterleukinsIBA 01/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2001
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2001
1	NF-KappaB Inhibitor alphaIBA 11/2000
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2000
1	Interleukin-1 (Interleukin 1)IBA 07/2000
1	EndotoxinsIBA 06/2000
1	Interleukin-2 (IL2)IBA 03/2000
1	Interleukin-4 (Interleukin 4)IBA 03/2000
1	Interleukin-5 (Interleukin 5)IBA 03/2000
1	Interleukin-8 (Interleukin 8)IBA 01/2000

Therapy/Procedure

2	Cardiopulmonary Bypass (Heart-Lung Bypass) 07/2000 - 03/2000
1	Therapeutics 01/2001
1	Intravenous Injections 05/2000
1	Extracorporeal Circulation 05/2000